Portfolio Companies 2026 for Amgen Ventures: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
Amgen Ventures accounts for 14 tracked companies with verified cap-table data, 14 of which disclose round sizes totalling $2.1B. The median disclosed raise is $144M, and the largest is ReCode Therapeutics at $570M, ahead of immatics biotechnologies ($312M) and Semisic ($222M).
The names that recur most often on these portfolio cap tables are Amgen Ventures (14 companies), Polaris Partners (3 companies), GV (3 companies), Alexandria Venture Investments (2 companies), Third Rock Ventures (2 companies), TDF Ventures (2 companies). By latest disclosed round, the market skews Series B (5), Series A (4), Series C (2), Other Equity (1).
Companies tracked: 14
Disclosed funding total: $2.1B across 14 companies
Median disclosed raise: $144M
Largest raise: ReCode Therapeutics — $570M
Stage mix: Series B 5 · Series A 4 · Series C 2 · Other Equity 1
